Taejon-si, South Korea

Tae Mi Kim


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tae Mi Kim - Innovator in Pharmaceutical Chemistry

Introduction

Tae Mi Kim is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at protecting tissues from ischemia-reperfusion injuries. His work has led to the filing of multiple patents that showcase his expertise and dedication to advancing medical science.

Latest Patents

Tae Mi Kim holds 2 patents that focus on benzopyran derivatives. His first patent involves benzopyran derivatives substituted with a thioxobenzoxazole derivative, along with their pharmaceutically acceptable salts and preparations. This invention is designed to protect the heart from ischemia-reperfusion both in vivo and in vitro. The pharmaceutical compositions containing these derivatives can effectively safeguard various tissues influenced by ischemia-reperfusion, including the heart, nervous cells, brain, and retinal cells.

The second patent pertains to benzopyran derivatives substituted with a benzimidazole derivative. Similar to the first, this invention aims to protect the heart from ischemia-reperfusion without the side effects associated with vasodilation. The pharmaceutical compositions derived from this invention can also be utilized for the treatment of diseases caused by ischemia-reperfusion.

Career Highlights

Throughout his career, Tae Mi Kim has worked with prominent companies in the industry. Notable among these are Schaeffler Technologies AG & Co. KG and Dongbu Hannong Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Tae Mi Kim has collaborated with several professionals in his field, including Hong Seok Lim and Dong Ha Lee. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.

Conclusion

Tae Mi Kim is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the protection of tissues from ischemia-reperfusion injuries. His innovative patents reflect his commitment to improving medical treatments and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…